Home › Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A
 

Keywords :   


Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A

2014-06-23 15:03:42| Chemicals - Topix.net

Dimension Therapeutics, a company focused on developing novel adeno-associated virus gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare for the development and commercialization of a novel gene therapy for the treatment of hemophilia A .

Tags: partner develop therapy gene

Category:Chemicals

Latest from this category

All news
05.11Teknos Poland Honored by Farby i Lakiery
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
04.11U.S. Green Building Council Announces 2024 Leadership Award Recipients
04.11ASTM International Publishes New Standards for FT4 Powder Rheometer Procedures
04.11Nippon Paint Marine Uses Biomimetics to Unlock Next Generation in Hull Coatings
04.11AkzoNobels Yacht Brands Lead the Way in Digital Training and Support
Chemicals »
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »